ResMed, Inc. (RMD) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $221.97 --0%
EPS Growth %: +5.5%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
ALZN, ASPU, RZLT, More
EPS Growth %: +5.5%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
ALZN, ASPU, RZLT, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q4 EPS of $0.64, $0.02 worse than the analyst estimate of $0.66. Revenue for the quarter came in at $415.2 million versus the consensus estimate of $433.42 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- UBS Downgrades NAVER Corp. (035420:KS) (NHNCF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
